Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2003

01-04-2003

Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas

Authors: Dr. Annamaria Colao, Mariagiovanna Filippella, Carolina Di Somma, Simona Manzi, Francesca Rota, Rosario Pivonello, Maria Gaccione, Michele De Rosa, Gaetano Lombardi

Published in: Endocrine | Issue 3/2003

Login to get access
Metadata
Title
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas
Authors
Dr. Annamaria Colao
Mariagiovanna Filippella
Carolina Di Somma
Simona Manzi
Francesca Rota
Rosario Pivonello
Maria Gaccione
Michele De Rosa
Gaetano Lombardi
Publication date
01-04-2003
Publisher
Humana Press
Published in
Endocrine / Issue 3/2003
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:20:3:279

Other articles of this Issue 3/2003

Endocrine 3/2003 Go to the issue

Mini-Review

Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis

OriginalPaper

Effect of 17β-estradiol on mRNA expression of large-conductance, voltage-dependent, and calcium-activated potassium channel α and β subunits in guinea pig

OriginalPaper

Somatostatin and somatostatin receptor physiology

EditorialNotes

Introduction

OriginalPaper

Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors

OriginalPaper

Octreoscan radioreceptor imaging
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits